Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 6735

Sherman Oaks, CA 91403

Study Summary:

For people with Alzheimer's there's no time to lose. Alzheimer's disease is a neurodegenerative disorder- a disorder in which the brain cells are lost. It is characterized by progressive loss of memory and cognitive function, such as movement control and decision-making ability. Alzheimer's disease is the most common cause of dementia in the elderly and affects about 18 million people worldwide- 5 million in the U.S. alone. Although there's currently no cure for Alzheimer's disease, research is under way to find a new investigational treatment aimed at slowing the progression of the disease. The current medications are mostly aimed at maximizing the remaining brain activity. That's why the ICARA study was created- to explore a new investigational treatment option.

If you are 50 to 88 years of age and have a diagnosis of probable Alzheimer's disease, you may be eligible to participate in the ICARA study.

Throughout the 83-week study, participants may receive the investigational drug, study-related physical exams and laboratory services at no charge. All participants will be monitored by a medical team, including a nurse or study coordinator and a physician.

Ask your doctor if the ICARA study is right for you.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.